Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Biologics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Product Category (Monoclonal Antibodies , Therapeutic Proteins and Hormones, Vaccines, Cell and Gene Therapies, Blood and Tissue Products), By Type of Molecule (Innovator , Biosimilars and Biobetters), By Route of Administration (Intravenous , Subcutaneous , Other Parenteral Routes), By Application (Oncology , Immunology and Autoimmune Diseases, Hematological Disorders, Cardiovascular and Metabolic Diseases, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Biologics Market size is forecast to increase from $507.45 Billion in 2026 to $967.45 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005907
Pages: 213 Pages

Biologics Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Monoclonal Antibodies , Recombinant Proteins, Vaccines, Cellular and Gene Therapies, Antisense and RNA Therapeutics), By Expression System (Mammalian Cell Cultures, Microbial Expression Systems , Insect Cell Cultures, Plant-based Expression Systems), By Manufacturing Technology (Fed-Batch Bioreactor Systems, Perfusion , Single-Use , Stainless Steel ), By Scale of Operation (Commercial Manufacturing, Clinical-scale Manufacturing), By Manufacturing Type (In-house Manufacturing, Outsourced) Companies, and Country Forecast, 2021 to 2034

Global Biologics Manufacturing Market size is forecast to increase from $92.9 Billion in 2026 to $200.59 Billion in 2034 at a CAGR of 10.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005906
Pages: 217 Pages

Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Process Development, GMP Manufacturing, Fill-Finish and Packaging, Analytical and QC Services), By Type (Mammalian, Microbial), By Product Type (Biologics , Biosimilars), By Scale (Pre-Clinical and Clinical, Commercial), By End-User (Small, Large Pharma) Companies, and Country Forecast, 2021 to 2034

Global Biologics Contract Development and Manufacturing Organization (CDMO) Market size is forecast to increase from $55.26 Billion in 2026 to $101.15 Billion in 2034 at a CAGR of 7.85% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005905
Pages: 223 Pages

Biological Skin Substitutes Market Size, Share and Growth Outlook, 2026: Analysis By Source Material (Human Allografts, Animal Xenografts, Autografts), By Product Type (Acellular Matrices, Cellularized Matrices, Bioengineered 3-D Skin), By Application (Chronic Ulcers , Burns, Surgical and Traumatic Wounds, Pediatric Congenital Defects, Cosmetic and Aesthetic Procedures), By End-User (Hospitals, Ambulatory Surgical Centers, Burn Care and Wound Care Centers, Military and Defense Medical Facilities) Companies, and Country Forecast, 2021 to 2034

Global Biological Skin Substitutes Market size is forecast to increase from $458.53 Million in 2026 to $906.97 Million in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005904
Pages: 228 Pages

Biological Safety Testing Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Instruments, Services, Consumables ), By Test Type (Sterility Testing, Bioburden Testing, Endotoxin Testing, Mycoplasma Testing, Virus Safety Testing, Residual Host Contaminant Detection Tests, Cell Line Authentication and Characterization Tests), By Application (Vaccines and Therapeutics, Cellular and Gene Therapy Products, Blood and Blood Products, Tissues and Tissue Products), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Biological Safety Testing Market size is forecast to increase from $6.28 Billion in 2026 to $13.76 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005903
Pages: 210 Pages

Biological Safety Cabinet Market Size, Share and Growth Outlook, 2026: Analysis By Type (Class I, Class II , Class III ), By Exhaust System (Ducted , Recirculating ), By Application (Drug Discovery & Pre-clinical R&D, Clinical & Diagnostic Testing, Biopharmaceutical Manufacturing), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinical Laboratories, Contract Development & Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Biological Safety Cabinet Market size is forecast to increase from $285.25 Million in 2026 to $512.54 Million in 2034 at a CAGR of 7.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005902
Pages: 216 Pages

Biological Indicators Market Size, Share and Growth Outlook, 2026: Analysis By Product Form (Self-Contained Biological Indicators , Biological Indicator Strips, Biological Test Kits, Indicator Suspensions), By Sterilization Method (Steam Sterilization, Ethylene Oxide , Hydrogen Peroxide , Dry Heat Sterilization, Formaldehyde Sterilization), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, Medical Device Manufacturers, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Biological Indicators Market size is forecast to increase from $663.69 Million in 2026 to $1292.65 Million in 2034 at a CAGR of 8.69% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005901
Pages: 227 Pages

Biological Implants Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Orthopedic & Trauma Implants, Cardiovascular Implants , Spinal Implants, Dental Implants, Ophthalmic Implants, Neurostimulator Implants), By Origin (Allografts, Autografts, Xenografts, Synthetic), By Material (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials ), By End-User (Hospitals, Ambulatory Surgical Centers , Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Biological Implants Market size is forecast to increase from $10.26 Billion in 2026 to $18.52 Billion in 2034 at a CAGR of 7.66% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005900
Pages: 228 Pages

Biological Data Visualization Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Sequencing Visualization Tools, Microscopy and Live-Cell Imaging Systems, Magnetic Resonance Imaging , X-Ray Crystallography Solutions), By Application (Genomic Analysis and Next-Generation Sequencing , Cell Biology and Organism Imaging, Molecular and Structural Analysis , Systems Biology and Network Analysis, Alignments, Phylogeny, and Evolution), By Platform (Windows-based Platforms, Linux-based Platforms, Mac OS-based Platforms), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Universities, Hospitals and Clinical Laboratories, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Biological Data Visualization Market size is forecast to increase from $962.95 Million in 2026 to $1904.7 Million in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005899
Pages: 220 Pages

Biologic Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Monoclonal Antibodies , Vaccines, Recombinant Hormones and Proteins, Cellular-based Biologics , Gene-based Biologics , Blood and Blood Products), By Source (Microbial-based Systems , Mammalian, Other Biological Sources ), By Route of Administration (Injectable , Oral), By Application (Oncology, Immunology and Autoimmune Diseases, Hematological Disorders, Cardiovascular Disorders, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Biologic Therapeutics Market size is forecast to increase from $646.58 Billion in 2026 to $1406.29 Billion in 2034 at a CAGR of 10.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005898
Pages: 230 Pages